Antitrust Antitrust

Servier tells EU judges patent settlements were no 'by object' breach of competition law

By Nicholas Hirst
  • 21 Oct 2021 05:26
  • 21 Oct 2021 05:26
Les Laboratoires Servier's patent settlements with producers of generic drugs had benefits that ought to have counterbalanced any initial competition concerns by the EU regulator, the company told the bloc's highest court.

Pleading late into yesterday evening at the EU Court of Justice, the French drugmaker launched several salvos against a lower

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News